Mesenchymal stem cells transfected with anti-miRNA-204-3p inhibit acute rejection after heart transplantation by targeting C-X-C motif chemokine receptor 4 (CXCR4) in vitro

BACKGROUND: Mesenchymal stem cells (MSCs) are a promising treatment for acute rejection (AR) after heart transplantation (HTx) owing to their immunomodulatory functions by promoting the transformation of macrophages from the M0 to M2 phenotype. However, it is undetermined whether surface expression...

Descripción completa

Detalles Bibliográficos
Autores principales: Tuo, Lei, Song, Hao, Jiang, Detian, Bai, Xiao, Song, Guangmin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8411131/
https://www.ncbi.nlm.nih.gov/pubmed/34527345
http://dx.doi.org/10.21037/jtd-21-1293

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8411131/
https://www.ncbi.nlm.nih.gov/pubmed/34527345
http://dx.doi.org/10.21037/jtd-21-1293

Ejemplares similares